Saudi FDA denies approval of camel urine supplement for cancer treatment
The Saudi Food and Drug Authority has refuted claims that it approved a camel urine-based supplement for cancer treatment, clarifying it is not authorized for this use.
Key Takeaways
AIThe Saudi Food and Drug Authority has denied reports that it approved a supplement derived from camel urine for the treatment of cancer, stating that the product is not authorized for this purpose.
In a post on its X (formerly Twitter) account as part of its “Rumor and Fact” segment, the authority clarified that the product is registered as a dietary supplement. It contains a blend of vitamins and minerals intended to help meet daily nutritional needs.
View the post on X
The authority emphasized that the product is only approved for nutritional purposes and does not carry any authorized therapeutic claims or approval for cancer treatment. It rejected circulating claims about its effectiveness in curing advanced cases of the disease.